Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Current Liabilities -----

What is the latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is - based on Mar2024 Consolidated results.
Year Current Liabilities
Mar2024-
Mar2023-
Mar2022-
Mar2017-
Mar2016-

How is Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Current Liabilities % Change
Mar2024 -
0
Mar2023 -
0
Mar2022 -
0
Mar2017 -
0
Mar2016 - -

Compare Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,788.8 Cr -6.1% -2.3% 52.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,686.0 Cr 0.8% -1.3% 10.6% Stock Analytics
DIVIS LABORATORIES ₹176,075.0 Cr 1.5% 2.3% 47.2% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 0.9% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹109,971.0 Cr -0.1% 7.2% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,121.0 Cr -2.7% -0.3% 9.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-6.1%

-2.3%

52.8%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses